Company Update | CH. Karnchang (CK TB/BUY/Bt12.30/Target: Bt17.70) The tone during CK’s analyst meeting was neutral. The company’s core operations remain solid, but it lacks new positive catalysts in the short to mid-term. New order signings are expected to be delayed until 2026 due to the political timeline. Given the undemanding valuation, we maintain BUY with a target price of Bt17.70.
Top Stories Company Update | CH. Karnchang (CK TB/BUY/Bt12.30/Target: Bt17.70) The tone during CK’s analyst meeting was neutral. The company’s core operations remain solid, but it lacks new positive catalysts in the short to mid-term. New order signings are expected to be delayed until 2026 due to the political timeline. Given the undemanding valuation, we maintain BUY with a target price of Bt17.70.
Greater China Company Results | Miniso (MNSO US/BUY/US$19.57/Target: US$26.80) Miniso's 3Q25 revenue rose 28% yoy, reaching the high end of its guidance, while adjusted operating profit grew 15% yoy. Miniso brand’s SSSG improved sequentially in both domestic market and overseas markets. For 4Q25, SSS in both domestic and US markets are expected to reach low teens. Revenue is expected to grow 25-30% yoy, and adjusted operating profit should grow by double digits yoy, with the yoy decline in adjus...
Company Results | CH. Karnchang (CK/BUY/Bt12.90/Target: Bt20.20) CK posted a net profit of Bt1.74b in 3Q25 (+73% yoy, +102% qoq), mainly supported by a one-off gain from the sale of shares in LPCL. Core operations also remained solid, with both revenue and gross margin showing strength. However, the company still lacks new catalysts in terms of order flow, and the road-collapse overhang continues to weigh on sentiment. CK is trading at an undemanding valuation. Maintain BUY. Target price: Bt20.2...
Top Stories Company Results | Central Pattana (CPN TB/BUY/Bt50.25/Target: Bt73.10) CPN reported a net profit of Bt5.4b in 3Q25 (+31.5% yoy, +26% qoq), supported by one-off items. Core earnings were strong as expected, improving both yoy and qoq. We anticipate the resilient core operational performance continuing into 4Q25. We are optimistic about CPN, given its resilient performance and positive business outlook with expansion plans. Maintain BUY. Target price: Bt73.10. Company Update | Char...
Company Update | CH. Karnchang (CK TB/BUY/Bt14.40/Target: Bt20.20) We expect CK’s 3Q25 earnings to increase both yoy and qoq, driven by one-off gains, while core operations should remain solid with stable revenue and margins, supported by seasonal strength in equity income. However, 4Q25 is likely to be a softer quarter due to seasonality. In addition, potential additional expenses related to the road collapse could weigh on sentiment in the near term. Overall, we maintain our Trading BUY reco...
Top Stories Company Results | IRPC (IRPC TB/HOLD/Bt1.02/Target: Bt1.20) IRPC’s 3Q25 performance turnaround to a net profit of Bt340m stemmed from better GRM and inventory gains offset by petrochemical weakness. 9M25 loss narrowed yoy to Bt2.2b from a core loss of Bt3.2b. We expect core earnings to turn positive in 4Q25 but we foresee potential huge inventory losses to reflect weaker oil prices in 4Q25. Company Update | CH. Karnchang (CK TB/BUY/Bt14.40/Target: Bt20.20) We expect CK’s 3Q25 ear...
Greater China Company Results | COSCO SHIPPING Holdings (1919 HK/HOLD/HK$13.67/Target: HK$14.54) CSH’s 3Q25 net profit fell 55% yoy to Rmb9.5b but beat expectations on resilient freight rates and higher volumes. The recent rebound in freight indices and suspension of US-China port fees should support 4Q25 earnings. While oversupply risks remain in 2026, accelerated scrapping could ease pressure. Its strong net cash position (63% of market cap) should allow CSH to navigate the downcycle with ...
Despite no new orders being signed, we remain optimistic about CK’s core business in 2H25, supported by a solid backlog and healthy gross margin. We also foresee upside risk to our earnings forecast from the sale of shares in LPCL during 2H25. Moreover, CK is trading at an undemanding valuation. Maintain BUY. Target price: Bt20.20.
KEY HIGHLIGHTS Update CH Karnchang (CK TB/BUY/Bt14.40/Target: Bt20.20) Optimistic on core operations; upside expected in 2H25 earnings. Origin Property (ORI TB/HOLD/Bt2.28/Target: Bt1.90) Backlog and asset disposals to underpin 2H25 earnings. PTT (PTT TB/BUY/Bt32.00/Target: Bt37.00) Remains financially robust with a healthy dividend.
GREATER CHINA Results Baidu Inc (9888 HK/HOLD/HK$87.25/Target: HK$88.00): 2Q25: Earnings missed expectations; release of next-gen Ernie bot in 2H25. Crystal International (2232 HK/BUY/HK$6.08/Target: HK$7.07): 1H25: Continuous margin expansion; strong order visibility into 3Q26. Fuyao Glass Industry Group (3606 HK/BUY/HK$67.50/Target: HK$85.00): 2Q25: Core earnings beat estimates by 8%. Maintain BUY. Raise target price from HK$68.00 to HK$85.00. Hong Kong Exchanges and Clearing (388 HK/BUY/HK$44...
CK is expected to report a net profit of Bt697m in 2Q25, increasing 43% yoy and 147% qoq. The improvement is anticipated to be underpinned by progress in projects under construction as well as equity income. Despite an absence of new orders signed in 1H25, we remain optimistic on CK’s earnings due to its solid backlog. Additionally, CK is trading at an undemanding valuation. Maintain BUY. Target price: Bt20.20.
KEY HIGHLIGHTS Results Advanced Info Service (ADVANC TB/BUY/Bt296.00/Target: Bt340.00) 2Q25: Results in line with our and consensus estimates. IRPC (IRPC TB/BUY/Bt1.02/Target: Bt1.20) 2Q25 Results: Losses were expected; better outlook in 3Q25. SVI (SVI TB/HOLD/Bt6.10/Target: Bt6.00) 2Q25: Earnings were weak and below our and market expectations Update CH Karnchang (...
GREATER CHINA Results BeOne Medicines (6160 HK/BUY/HK$182.70/Target: HK$240.00): 2Q25: Results beat; expects revenue and margins to expand further. Cathay Pacific Airways (293 HK/SELL/HK$10.85/Target: HK$10.23): 1H25: Results broadly in line. Cargo facing higher uncertainties in 2H25. Downgraded to SELL. Update AIA Group (1299 HK/BUY/HK$73.55/Target: HK$91.00): 1H25 results preview: Solid VONB and earnings growth. Xiaomi Corp (1810 HK/BUY/HK$54.00/Target: HK$69.20): 2Q25 results preview: Expect ...
The BOT attended our seminar to provide our clients with Thailand's economic outlook for 2H25. The BOT has revised its 2025 GDP forecast from 2.0% to 2.3% in the meeting. It foresees a softening of exports in 3Q25, due to the front-loading of exports in 1H25. The PM has been suspended, with a caretaker in charge, but there should be no impact on 2026’s budget. We highlight four sectors related to the BOT event. Top picks: KBANK, MTC, CPALL and STECON.
GREATER CHINA Strategy Alpha Picks: July Conviction Calls Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. Sector Online Games Upcoming new game releases to capitalise on the summer holiday season. INDONESIA Strategy Alpha Picks: Good Performances In June Our new alpha picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA...
GREATER CHINA Sector Insurance Weighing the risks and returns. Update Sunny Optical (2382 HK/BUY/HK$65.15/Target: HK$100.00) Takeaways from 2025 Investor Day. Maintain BUY. INDONESIA Strategy Challenging Macro Environment Adds To Case For Rate Cut Our top picks are BBCA, BBRI, ANTM, AMRT, ICBP, CMRY and ERAA. MALAYSIA Sector Automobile ...
GREATER CHINA Strategy Alpha Picks: June Conviction Calls Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and TCOM. Update Qingdao Port International (6198 HK/NOT RATED/Price: HK$6.54) Key takeaways from NDR. INDONESIA Update Sumber Alfaria Trijaya (AMRT IJ/BUY/Rp2,620/Target: Rp3,000) Synergy potential from Lawson; expansion outside Java remains intact. MALAYSIA Strategy 1Q25 Results Wrap-Up ...
Following the analyst meeting, we maintain a positive outlook on CK’s construction business. Although no new contracts have been signed recently, the company still holds a sizeable backlog that will continue to support revenue. We expect earnings momentum to accelerate in 2Q–3Q25. Additionally, we believe CK will benefit from positive sentiment as government project bidding gradually resumes in 2H25. Maintain BUY. Target price: Bt20.20.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.